本研究旨在进行一项随机对照试验，以评估冷静干预和ConquerFear干预对中国晚期癌症患者癌症进展恐惧的影响。
适应症：Advanced or Metastatic Cancer、Fear of Cancer Progression、Metacognition-based Intervention、Supportive-expressive Based Intervention、Psychooncology
入组条件
纳入标准
- Cantonese- or Mandarin-speaking Chinese patients recently diagnosed with advanced or metastatic (i.e. stage III or IV) cancer
- are the age of 18 years or above
排除标准
- Patients with major communication difficulties
- are being unwilling or unable to commit 6 psychotherapy sessions
入组条件维持 ClinicalTrials.gov 原始英文登记资料，实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源：ClinicalTrials.gov，每两周自动更新，最后同步：2026年10月8日。